Nymox Pharmaceutical Corp
NYMX
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.24M
Close$
Share Statistics
| Market cap | $18.24 Million |
|---|---|
| Enterprise Value | $18.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 0.82 |
| Outstanding Shares | 91,265,140 |
Return
| Return on Equity | 294.96% |
|---|---|
| Return on Assets | -3131.37% |
| Return on Invested Capital | 79.60% |
Valuation & Multiples
| P/E Ratio | -2.02 |
|---|---|
| PEG | 1.62 |
| Price to Sales | - |
| Price to Book Ratio | -0.2 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.26 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | -0.28 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data